Pharmgate Animal Health announces Deracin®, a generic (ANADA) alternative to Aureomycin®, has been approved by the Food and Drug Administration for use in combination with the antimicrobial Denagard® for swine. This combination of Deracin® (chlortetracycline) and Denagard® (tiamulin hydrogen fumarate) is approved for the treatment of swine dysentery, enteritis and pneumonia.
“The new combination of Deracin® and Denagard® provides an economical, easy-to-use tool to treat sick pigs,” says Colin Gray, president and CEO of Pharmgate Animal Health. “Deracin® gives producers and swine veterinarians a choice in chlortetracycline without the need to change treatment protocols or question how it will work.”
Deracin® is a broad-spectrum medicated feed article (MFA) that is effective against gram-positive and gram-negative organisms that cause diseases such as enteritis, pneumonia, ileitis, leptospirosis and jowl abscesses. Deracin® is readily absorbed via oral administration, so it quickly reaches effective blood and lung concentrations. It is a veterinary feed directive (VFD) drug to be used by or on the order of a licensed veterinarian.
Pharmgate’s pioneer NADA chlortetracycline product, Pennchlor®, continues to be approved for combination use with Denagard®. Like Deracin®, Pennchlor® is a broad-spectrum MFA and effective against gram-positive and gram-negative organisms. Pennchlor® is highly concentrated for reduced handling and delivers versatility with a wide range of approved combinations.
“Our diverse product portfolio demonstrates our ongoing commitment to provide the industry useful, effective, high-quality products,” says Gray. “Offering both products provides producers, veterinarians and feed mills chlortetracycline treatment options.”
June 18, 2019 - Pharmgate Animal Health